Dysfunction of Mitochondrial ATP Production As a Target for Personalized Cancer Therapy

Publisher： Bentham Science Publishers

E-ISSN： 1875-6913|7|1|27-39

ISSN： 1875-6921

Source： Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics), Vol.7, Iss.1, 2009-03, pp. : 27-39

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Mitochondrial VDAC1: Function in Cell Life and Death and a Target for Cancer Therapy

By  

Current Medicinal Chemistry, Vol. 19, Iss. 5, 2012-02 ,pp. : 714-735

Bentham Science Publishers

Access to resources Recommend Favorite

Mitochondrial Dysfunction and Antioxidant Therapy in Sepsis

By  

Infectious Disorders - Drug Targets (Formerly Current Drug Targets - Infectious Disorders), Vol. 12, Iss. 2, 2012-04 ,pp. : 161-178

Bentham Science Publishers

Access to resources Recommend Favorite

Personalized cancer therapy – the key to the future

By Sikora Karol  

Pharmacogenomics, Vol. 5, Iss. 3, 2004-04 ,pp. : 225-228

Future Medicine

Access to resources Recommend Favorite

Heparanase as a Target in Cancer Therapy

By  

Current Cancer Drug Targets, Vol. 14, Iss. 3, 2014-03 ,pp. : 286-293

Bentham Science Publishers

Access to resources Recommend Favorite

The Centrosome: A Target for Cancer Therapy

By  

Current Cancer Drug Targets, Vol. 11, Iss. 5, 2011-01 ,pp. : 600-612

Bentham Science Publishers

Access to resources Recommend Favorite